XBI icon

SPDR S&P Biotech ETF

764 hedge funds and large institutions have $10.2B invested in SPDR S&P Biotech ETF in 2024 Q3 according to their latest regulatory filings, with 88 funds opening new positions, 238 increasing their positions, 269 reducing their positions, and 73 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding in top 10

Funds holding in top 10:

more capital invested

Capital invested by funds: $ → $

more ownership

Funds ownership:

1% more funds holding

Funds holding: 756764 (+8)

12% less repeat investments, than reductions

Existing positions increased: 238 | Existing positions reduced: 269

16% less call options, than puts

Call options by funds: $2.8B | Put options by funds: $3.33B

Holders
764
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
21
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$2.8B
Puts
$3.33B
Net Calls
Net Calls Change

Top Buyers

1 +$606M
2 +$159M
3 +$141M
4
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$99.1M
5
Goldman Sachs
Goldman Sachs
New York
+$78M
Name Holding Trade Value Shares
Change
Change in
Stake
601
$207K
602
$204K
603
$203K
604
$202K
605
$202K
606
$193K
607
$188K
608
$182K
609
$178K
610
$171K
611
$167K
612
$166K
613
$164K
614
$161K
615
$160K
616
$156K
617
$155K
618
$153K
619
$153K
620
$148K
621
$148K
622
$148K
623
$148K
624
$147K
625
$144K